Does Portal Hypertension Increase the Risk of Helicobacter pylori Infection and Pre-Malignant Gastric Lesions?

Rui Gaspar1, Pedro Cardoso1, Tiago Ribeiro1

  • 1Gastroenterology and Hepatology, Unidade Local de Saúde de São João, Porto 4200, Portugal.

PubMed

Insights

Portal hypertension in cirrhosis is linked to gastropathy, but not Helicobacter pylori infection or pre-malignant lesions. Spleen and liver stiffness measurements correlate with gastropathy, not H. pylori or precancerous changes.

Area of Science:

  • Gastroenterology and Hepatology
  • Diagnostic Imaging
  • Oncology

Background:

  • Portal hypertension is a critical prognostic factor in cirrhosis, increasing mortality and complications.
  • Hepatic venous pressure gradient is the gold standard for diagnosis, with spleen stiffness emerging as a non-invasive tool.
  • The relationship between portal hypertension, Helicobacter pylori infection, and pre-malignant gastric lesions remains underexplored.

Purpose of the Study:

  • To investigate the association between portal hypertension, assessed by liver and spleen elastography, and Helicobacter pylori infection.
  • To evaluate the correlation between elastography findings and pre-malignant gastric lesions in cirrhotic patients.
  • To determine if spleen and liver stiffness measurements are linked to H. pylori or precancerous gastric changes.

Main Methods:

  • An observational study included 155 cirrhotic patients from December 2020 to December 2022.
  • All participants underwent upper endoscopy and liver/spleen elastography by a blinded operator.
  • Histological analysis assessed H. pylori infection and pre-malignant gastric lesions (gastric atrophy, metaplasia).

Main Results:

  • Liver stiffness median: 24.4 kPa; Spleen stiffness median: 49.1 kPa.
  • Portal hypertensive gastropathy was present in 32.9% of patients.
  • H. pylori infection (34.8%), gastric atrophy (35.5%), and gastric metaplasia (38.7%) were observed.
  • Liver and spleen stiffness correlated with portal hypertensive gastropathy (p < 0.01).
  • No association was found between stiffness measurements and H. pylori infection or pre-malignant lesions.

Conclusions:

  • H. pylori infection and pre-malignant gastric lesions occur in nearly one-third of cirrhotic patients.
  • These conditions are not associated with liver or spleen stiffness measurements.
  • Liver and spleen stiffness measurements are significantly associated with portal hypertensive gastropathy in cirrhotic patients.

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
168
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
585
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
116
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
324
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
409
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
390